AI-Enhanced Nanophotonic Heterochain Sensor Enables Multiplexed Biomarker Detection across Serum, Urine, and Saliva for Stroke Differentiation
- 21 May 2026
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
Abstract
Background: Rapid and accurate identification of stroke subtype is critical for timely intervention, yet current diagnostic assays are limited by long turnaround times, dependency on centralized laboratories, and insufficient sensitivity in the ultra-early stage. Methods: We developed a nanophotonic heterochain biosensing platform integrated with deep learning−assisted image analysis for multiplex detection of S100B, GFAP, and UCH-L1 in serum, urine, and saliva. The system consists of antibody-functionalized PS@Se heterochain biosensor, portable smartphone-based imaging, and a cloud-enabled analysis pipeline. Analytical validation was performed using recombinant protein standards, followed by clinical evaluation in ischemic stroke, intracerebral hemorrhage, and healthy controls. Results: The biosensor achieved picogram-level sensitivity with strong linearity (overall R2 = 0.9583), high recovery (104.7%), and acceptable reproducibility (CV = 24.4%). Clinical validation demonstrated significant elevations of biomarkers in patient groups compared to controls, with distinct profiles between ischemic and hemorrhagic stroke. Integration of biomarker panels using logistic regression improved diagnostic performance over individual assays, enabling accurate discrimination of stroke subtypes within a clinically actionable window. Conclusion: This portable, AI-integrated biosensing system enables ultra-early, multiplexed, and quantitative detection of brain injury biomarkers, with potential to transform point-of-care stroke diagnostics in both clinical and field settings.Keywords
Funding Information
- National Major Science and Technology Projects of China (2023ZD0515900)
- National Health Commission of the People's Republic of China (GWJJMB202510021136)
- National Natural Science Foundation of China (T2394483)
This publication has 48 references indexed in Scilit:
- Emerging Biosensor Technologies for Stroke Biomarker Detection: A Comprehensive OverviewAnalytical Science Advances, 2025
- Artificial intelligence entering the pathology arena in oncology: current applications and future perspectivesAnnals of Oncology, 2025
- Sensitivity evaluation of an optical microfiber featuring interfaces with various gold nanoparticle morphologies: Application to the GFAP detectionBiosensors and Bioelectronics, 2024
- Printed Divisional Optical Biochip for Multiplex Visualizable Exosome Analysis at Point‐of‐CareAdvanced Materials, 2023
- A magnetoimpedance biosensor microfluidic platform for detection of glial fibrillary acidic protein in blood for acute stroke classificationBiosensors and Bioelectronics, 2022
- Development of an electrochemical impedance spectroscopy based biosensor for detection of ubiquitin C-Terminal hydrolase L1Biosensors and Bioelectronics, 2022
- Evaluation of Glial and Neuronal Blood Biomarkers Compared With Clinical Decision Rules in Assessing the Need for Computed Tomography in Patients With Mild Traumatic Brain InjuryJAMA Network Open, 2022
- Salivary biomarkers of neurodegenerative and demyelinating diseases and biosensors for their detectionAgeing Research Reviews, 2022
- Ischemic stroke in cancer patients: A review of an underappreciated pathologyAnnals of Neurology, 2018
- Investigation of UCH-L1 levels in ischemic stroke, intracranial hemorrhage and metabolic disorder induced impaired consciousnessThe American Journal of Emergency Medicine, 2017